Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.003,83
0,00%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Avidity Biosciences Inc (RNA) Avidity Biosciences Inc (RNA) Notizie

Avidity Biosciences Inc

RNA
38,6888
-1,27 (-3,18%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 01:41:05
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/6/202401:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/6/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/6/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/6/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202423:05EDGAR2Form 8-K - Current report
14/6/202422:58EDGAR2Form 8-K - Current report
14/6/202422:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/6/202415:00PRNUSAvidity Biosciences to Participate in Upcoming Investor..
14/6/202402:00PRNUSAvidity Biosciences, Inc. Announces Pricing of Public..
13/6/202422:26EDGAR2Form 144 - Report of proposed sale of securities
12/6/202422:22EDGAR2Form 144 - Report of proposed sale of securities
12/6/202422:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/6/202422:01PRNUSAvidity Biosciences, Inc. Announces Proposed Public Offering..
12/6/202413:02EDGAR2Form 8-K - Current report
12/6/202413:00PRNUSAvidity Announces Unprecedented AOC 1020 Data from Phase 1/2..
05/6/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:27EDGAR2Form 144 - Report of proposed sale of securities
29/5/202422:05PRNUSAvidity Biosciences to Present Preliminary Data from Phase..
21/5/202422:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
17/5/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202400:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/5/202415:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/5/202415:09EDGAR2Form 8-K - Current report
15/5/202415:00PRNUSAvidity Biosciences Announces Appointment of Simona..
09/5/202422:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
09/5/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:07EDGAR2Form 8-K - Current report
09/5/202422:05PRNUSAvidity Biosciences Reports First Quarter 2024 Financial..
08/5/202422:05PRNUSAvidity Biosciences to Participate in Upcoming Investor..
08/5/202412:00PRNUSAvidity Biosciences Receives FDA Breakthrough Therapy..
08/5/202403:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/4/202422:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
27/3/202414:00PRNUSAvidity Biosciences to Participate in Upcoming Investor..
21/3/202421:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
08/3/202422:23EDGAR2Form 144 - Report of proposed sale of securities
05/3/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202413:07EDGAR2Form 8-K - Current report
04/3/202413:00PRNUSAvidity Biosciences Announces Positive AOC 1001 Long-term..
01/3/202422:31EDGAR2Form 144 - Report of proposed sale of securities
29/2/202422:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202422:06EDGAR2Form 8-K - Current report
29/2/202418:00PRNUSAvidity Biosciences Honors Rare Disease Day®
29/2/202413:00PRNUSAvidity Biosciences Announces Oversubscribed $400 Million..
28/2/202423:32EDGAR2Form S-3ASR - Automatic shelf registration statement of..
28/2/202422:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202422:05PRNUSAvidity Biosciences Reports Fourth Quarter and Year-End 2023..
27/2/202415:00PRNUSAvidity Biosciences to Participate in Upcoming Investor..
21/2/202422:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
20/2/202415:00PRNUSAvidity Biosciences Receives FDA Rare Pediatric Disease..
15/2/202423:00PRNUSAvidity Biosciences to Present New AOC 1001 Long-term..
Apertura: 40,01 Min: 38,76 Max: 42,00
Chiusura: 39,96

La tua Cronologia

NASDAQ
RNA
Avidity Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network